NVOS (Novo Integrated Sciences) Cyclically Adjusted FCF per Share: $-0.79 (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences Cyclically Adjusted FCF per Share?

Novo Integrated Sciences NVOS +337.50% 12 Cyclically Adjusted FCF per Share is $-0.79 as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Novo Integrated Sciences's adjusted free cash flow per share for the three months ended in May. 2024 was $-0.035. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.79 for the trailing ten years ended in May. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-01), Novo Integrated Sciences's current stock price is $0.0035. Novo Integrated Sciences's Cyclically Adjusted FCF per Share for the quarter that ended in May. 2024 was $-0.79. Novo Integrated Sciences's Cyclically Adjusted Price-to-FCF of today is .


Novo Integrated Sciences  (OTCPK:NVOS) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Novo Integrated Sciences Cyclically Adjusted FCF per Share Related Terms


Novo Integrated Sciences Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences Cyclically Adjusted FCF per Share Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.11 -7.05 -2.65 -1.67 -0.96

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.17 -0.96 -0.87 -0.82 -0.79

NVOS vs BACK, NHLG, FCHS: Cyclically Adjusted FCF per Share Comparison

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Cyclically Adjusted Price-to-FCF falls into.


NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novo Integrated Sciences's adjusted Free Cash Flow per Share data for the three months ended in May. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of May. 2024 (Change)*Current CPI (May. 2024)
=-0.035/314.0690*314.0690
=-0.035

Current CPI (May. 2024) = 314.0690.

Novo Integrated Sciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.205 238.343 -0.270
201409 -0.178 238.031 -0.235
201412 -0.219 234.812 -0.293
201503 -0.139 236.119 -0.185
201506 -0.403 238.638 -0.530
201509 -0.231 237.945 -0.305
201512 -0.068 236.525 -0.090
201603 -0.095 238.132 -0.125
201606 -0.205 241.018 -0.267
201609 -0.089 241.428 -0.116
201612 -0.102 241.432 -0.133
201703 -0.238 243.801 -0.307
201708 -0.222 245.519 -0.284
201711 -0.176 246.669 -0.224
201802 -0.079 248.991 -0.100
201805 -0.189 251.588 -0.236
201808 -0.091 252.146 -0.113
201811 -0.114 252.038 -0.142
201902 -0.140 252.776 -0.174
201905 -0.044 256.092 -0.054
201908 -0.132 256.558 -0.162
201911 -0.133 257.208 -0.162
202002 -0.122 258.678 -0.148
202005 0.066 256.394 0.081
202008 -0.007 259.918 -0.008
202011 -0.063 260.229 -0.076
202102 -0.119 263.014 -0.142
202105 0.059 269.195 0.069
202108 -0.281 273.567 -0.323
202111 -0.327 277.948 -0.369
202202 -0.808 283.716 -0.894
202205 -1.190 292.296 -1.279
202208 0.218 296.171 0.231
202211 -0.082 297.711 -0.087
202302 -0.111 300.840 -0.116
202305 -0.060 304.127 -0.062
202308 -0.015 307.026 -0.015
202311 -0.129 307.051 -0.132
202402 -0.097 310.326 -0.098
202405 -0.035 314.069 -0.035

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.79 mean?
Novo Integrated Sciences (NVOS) has a Cyclically Adjusted FCF per Share of $-0.79 as of May. 2024. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' Cyclically Adjusted FCF per Share too high?
Novo Integrated Sciences' current Cyclically Adjusted FCF per Share is $-0.79. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' Cyclically Adjusted FCF per Share compare to BACK and NHLG?
Novo Integrated Sciences' Cyclically Adjusted FCF per Share of $-0.79 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Novo Integrated Sciences and its competitors. Novo Integrated Sciences's current Cyclically Adjusted FCF per Share is $-0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current Cyclically Adjusted FCF per Share of $-0.79. The current Cyclically Adjusted FCF per Share is $-0.79. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current Cyclically Adjusted FCF per Share is $-0.79 as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price